Literature DB >> 24194557

Molecular epidemiology and genetic diversity of Entamoeba species in a chelonian collection.

Gabriela García1, Fernando Ramos1, Rodrigo Gutiérrez Pérez1, Jorge Yañez2, Mónica Salmerón Estrada3, Lilian Hernández Mendoza1, Fernando Martinez-Hernandez4, Paul Gaytán2.   

Abstract

Veterinary medicine has focused recently on reptiles, due to the existence of captive collections in zoos and an increase in the acquisition of reptiles as pets. The protozoan parasite, Entamoeba can cause amoebiasis in various animal species and humans. Although amoebiasis disease is remarkably rare in most species of chelonians and crocodiles, these species may serve as Entamoeba species carriers that transmit parasites to susceptible reptile species, such as snakes and lizards, which can become sick and die. In this study, we identified the Entamoeba species in a population of healthy (disease-free) chelonians, and evaluated their diversity through the amplification and sequencing of a small subunit rDNA region. Using this procedure, three Entamoeba species were identified: Entamoeba invadens in 4.76 % of chelonians, Entamoeba moshkovskii in 3.96 % and Entamoeba terrapinae in 50 %. We did not detect mixed Entamoeba infections. Comparative analysis of the amplified region allowed us to determine the intra-species variations. The E. invadens and E. moshkovskii strains isolated in this study did not exhibit marked differences with respect to the sequences reported in GenBank. The analysis of the E. terrapinae isolates revealed three different subgroups (A, B and C). Although subgroups A and C were very similar, subgroup B showed a relatively marked difference with respect to subgroups A and C (Fst = 0.984 and Fst = 1.000, respectively; 10-14 % nucleotide variation, as determined by blast) and with respect to the sequences reported in GenBank. These results suggested that E. terrapinae subgroup B may be either in a process of speciation or belong to a different lineage. However, additional research is necessary to support this statement conclusively.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24194557     DOI: 10.1099/jmm.0.061820-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  5 in total

1.  Prevalence of two Entamoeba gingivalis ST1 and ST2-kamaktli subtypes in the human oral cavity under various conditions.

Authors:  Gabriela Garcia; Fernando Ramos; Juan Maldonado; Antonio Fernandez; Jorge Yáñez; Lilian Hernandez; Paul Gaytán
Journal:  Parasitol Res       Date:  2018-07-09       Impact factor: 2.289

2.  Gene migration for re-emerging amebiasis in Iran's northwest-Iraq borders: a microevolutionary scale for reflecting epidemiological drift of Entamoeba histolytica metapopulations.

Authors:  Asad Mohammadzadeh; Adel Spotin; Mahmoud Mahami-Oskouei; Ali Haghighi; Nozhat Zebardast; Kobra Kohansal
Journal:  Parasitol Res       Date:  2016-10-20       Impact factor: 2.289

3.  Prevalence and Molecular Identification of Entamoeba spp. in Non-human Primates in a Zoological Garden in Nanjing, China.

Authors:  Xinchao Liu; Guangbin Bao; Menglong Yue; Yi Fang; Yueyue Gu; Wenchao Li; Youfang Gu; Wangkun Cheng; Mingmin Lu
Journal:  Front Vet Sci       Date:  2022-05-30

4.  A new subtype of Entamoeba gingivalis: "E. gingivalis ST2, kamaktli variant".

Authors:  Gabriela García; Fernando Ramos; Fernando Martínez-Hernández; Lilian Hernández; Jorge Yáñez; Paul Gaytán
Journal:  Parasitol Res       Date:  2018-02-10       Impact factor: 2.289

5.  Diversity, geographical distribution, and prevalence of Entamoeba spp. in Brazil: a systematic review and meta-analysis.

Authors:  Andernice Dos Santos Zanetti; Antonio Francisco Malheiros; Tatiane Amorim de Matos; Carolina Dos Santos; Paula Franciene Battaglini; Luciana Melhorança Moreira; Larissa Maria Scalon Lemos; Solange Kimie Ikeda Castrillon; Denise da Costa Boamorte Cortela; Eliane Ignotti; Omar Ariel Espinosa
Journal:  Parasite       Date:  2021-03-30       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.